98665-21-5

Basic information

• Product Name: Ganolucidic acid A
• Synonyms: Ganolucidic acid A;15α-Hydroxy-3,11,23-trioxo-5α-lanost-8-en-26-oic acid
• CAS NO: 98665-21-5
• Molecular Formula: C30H44O6
• Molecular Weight: 500.68
• Mol File: 98665-21-5.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 654.1°C at 760 mmHg
• Flash Point: 363.4°C
• Appearance: /
• Density: 1.18g/cm³
• Vapor Pressure: 7E-20mmHg at 25°C
• Refractive Index: 1.553
• PKA: 4.78±0.23(Predicted)
• CAS DataBase Reference: Ganolucidic acid A(CAS DataBase Reference)
• NIST Chemistry Reference: Ganolucidic acid A(98665-21-5)
• EPA Substance Registry System: Ganolucidic acid A(98665-21-5)

Safety Data

• Hazardous Substances Data: 98665-21-5(Hazardous Substances Data)

Usage

Description

Ganolucidic acid A is a natural triterpene compound derived from the fruiting bodies of Ganoderma lucidum, commonly known as the reishi mushroom. It is recognized for its diverse medicinal properties, such as anti-inflammatory, anti-tumor, and immunomodulatory effects. Ganolucidic acid A has demonstrated cytotoxic activity against a range of cancer cell lines and has the potential to enhance immune system function and regulate inflammation, positioning it as a promising natural therapy for various health conditions.

Uses

Used in Cancer Treatment:
Ganolucidic acid A is used as a potential cancer therapeutic agent for its cytotoxic effects on various cancer cell lines. It is being studied for its ability to target and eliminate cancer cells while minimizing damage to healthy cells, offering a natural alternative to conventional cancer treatments.
Used in Immunomodulation:
In the field of immunology, Ganolucidic acid A is used as an immunomodulatory agent to enhance the immune system's function. It has shown promise in stimulating the immune response, which can be beneficial in fighting infections and supporting overall health.
Used in Anti-Inflammatory Applications:
Ganolucidic acid A is utilized as an anti-inflammatory agent to help regulate inflammation in the body. Its properties can be harnessed to alleviate symptoms associated with inflammatory conditions and contribute to the management of chronic inflammatory diseases.
As research continues, the potential applications of Ganolucidic acid A may expand, offering new avenues for natural health solutions and therapeutic interventions.

InChI:InChI=1/C30H44O6/c1-16(12-18(31)13-17(2)26(35)36)20-14-24(34)30(7)19-8-9-22-27(3,4)23(33)10-11-28(22,5)25(19)21(32)15-29(20,30)6/h16-17,20,22,24,34H,8-15H2,1-7H3,(H,35,36)/t16-,17-,20-,22+,24+,28+,29-,30-/m1/s1